somatropin + No treatment given + No treatment given
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
22
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Foetal Growth Problem
Conditions
Foetal Growth Problem, Small for Gestational Age
Trial Timeline
Feb 1, 2009 → Jan 1, 2011
NCT ID
NCT00787878About somatropin + No treatment given + No treatment given
somatropin + No treatment given + No treatment given is a pre-clinical stage product being developed by Novo Nordisk for Foetal Growth Problem. The current trial status is completed. This product is registered under clinical trial identifier NCT00787878. Target conditions include Foetal Growth Problem, Small for Gestational Age.
Hype Score Breakdown
Clinical
5
Activity
2
Company
9
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00787878 | Pre-clinical | Completed |
Competing Products
8 competing products in Foetal Growth Problem
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| somatropin + somatropin + somatropin | Novo Nordisk | Approved | 84 |
| somatropin | Novo Nordisk | Phase 3 | 76 |
| somatropin | Novo Nordisk | Phase 3 | 76 |
| somatropin | Novo Nordisk | Pre-clinical | 22 |
| somatropin + somatropin | Novo Nordisk | Phase 3 | 76 |
| somatropin | Novo Nordisk | Approved | 84 |
| somatropin | Novo Nordisk | Phase 3 | 76 |
| somatropin + somatropin | Novo Nordisk | Approved | 84 |